The earlier breast cancer is found, the easier it is to treat. Therefore, It is vitally important that all women have access to the latest innovations that can detect the disease at its earliest stage. The experts agree that worldwide, breast cancer is now the most common form of cancer in women, and it is on the increase.

Worldwide, around 2.1 million newly diagnosed female breast cancer cases were reported in 2018 with over 600,000 deaths. In the USA, around 1 in 8 women (12%) will develop invasive breast cancer. This is the driving force of the work being done by ScreenPoint Medical, the developers of Transpara Breast AI.

While deaths due to breast cancer have been reduced by 40% in the past 20 years, we don’t think that’s good enough. We want to make a real difference in the quality of breast care and expect that, with Transpara Breast Care, even greater reductions will be achieved.

Transpara Breast Care is based on a powerful artificial intelligence (AI) solution built with deep learning techniques. This tool is used by your radiologist when she is reviewing your mammogram. It has been clinically proven that when working together, your radiologist and Transpara can detect more cancers than when reading alone. Transpara is not designed to replace your radiologist but, rather, to make it possible for her to find even more cancers earlier than she might have found on her own.

This means that, if you need it, treatment can be started sooner giving you a better chance of a successful outcome, a better chance to beat breast cancer!